title: Improved systemic chemotherapy for metastatic testicular choriocarcinoma can result in excellent prognosis for life and vision.
authors.forename: Rahul N
authors.initials: RN
authors.lastname: Khurana
authors.forename: Cathy
authors.initials: C
authors.lastname: DiBernardo
authors.forename: James T
authors.initials: JT
authors.lastname: Handa
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002822:Choriocarcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D002830:Choroid Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D009919:Orchiectomy; D011379:Prognosis; D013736:Testicular Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D014463:Ultrasonography; D014792:Visual Acuity; D020255:Vitreous Detachment / Q000000981:diagnostic imaging; D014823:Vitreous Hemorrhage / Q000000981:diagnostic imaging
chemical_list: D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin